Eastman Chemical EMN Restructuring, Settlement and Impairment Provisions
Restructuring, Settlement and Impairment Provisions at other companies
Other financials
Where this comes from
Reported directly by Eastman Chemical in its filing.
Tagged under the XBRL concept us-gaap:RestructuringSettlementAndImpairmentProvisions.
The official record: Eastman Chemical’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eastman Chemical's restructuring, settlement and impairment provisions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eastman Chemical's restructuring, settlement and impairment provisions?
- Eastman Chemical (EMN) reported restructuring, settlement and impairment provisions of $9M in Q1 2026.
- How has Eastman Chemical's restructuring, settlement and impairment provisions changed year-over-year?
- Eastman Chemical's restructuring, settlement and impairment provisions decreased by 0.0% year-over-year, from $9M to $9M.
- What is the long-term trend for Eastman Chemical's restructuring, settlement and impairment provisions?
- Over 4 years (2021 to 2025), Eastman Chemical's restructuring, settlement and impairment provisions has grown at a 19.5% compound annual growth rate (CAGR), from $47M to $96M.
- What does restructuring, settlement and impairment provisions mean?
- This metric captures non-recurring charges related to organizational restructuring, asset write-downs, or legal settlements. These items are typically excluded from core operating performance to provide a clearer view of ongoing business trends.